Navigation Links
MediciGlobal Wins Four International 2009 Communications Awards for Patient Recruitment and Retention

PHILADELPHIA and LONDON, June 17 /PRNewswire/ -- MediciGlobal, a leading speciality patient recruitment-retention company, receives four separate Awards of Distinction in The 2009 Communicator Awards from the International Academy of the Visual Arts. The Communicator Awards is the leading international awards program honouring creative excellence for Communications Professionals.

MediciGlobal won awards on behalf of three global pharmaceutical clients in four distinct disease areas:

    Depression                            Promotional Study Site Kit
    Menopause                             Promotional Study Site Kit
    Clinically Isolated Syndrome          Patient Education Programme
     (Pre-diagnosed Multiple Sclerosis)
    Teen Migraine                         Patient Recruitment Campaign

"We know the importance of developing high quality programmes that adhere to health literacy guidelines," says Liz Moench, MediciGlobal's President and CEO. "Study sites rightly expect materials of high quality to hand to their patients," adds Moench.

MediciGlobal knows that recruitment and retention materials are most effective when study researchers and their clinical coordinators are proud to use them, and when patients value the information they provide about clinical trial participation.

Since 2007, the company has received 10 national and international awards for its patient recruitment and retention programmes. These awards recognise MediciGlobal's work in support of CNS, endocrinology, oncology, and infectious disease clinical trials. "Receiving recognition such as this, further attests that our programmes are innovative, patient-friendly and industry-leading," notes Liz Moench.

Winners for the 2009 awards were chosen from over 9,000 world-wide entries, and were judged by the International Academy of the Visual Arts, an invitation-only professional organization consisting of top-tier professionals from leading media, communications, advertising, and marketing firms.

About MediciGlobal

MediciGlobal based in the U.S. and U.K., is a specialty patient recruitment - retention company, developing patient-centric programmes for clinical trials of all sizes, and in countries around the globe. MediciGlobal's patient recruitment and retention programmes ensure that biopharmaceutical and life sciences companies meet or exceed their clinical study timelines. MediciGlobal is one of few companies focused solely on patient recruitment and retention for almost two decades.

About The Communicator Awards

The Communicator Awards is the leading international awards program honouring creative excellence for communications professionals. The Communicator Awards is an annual competition honouring the best in advertising, corporate communications, public relations and brand-identity work for print, video, interactive and audio. Visit for more information.

SOURCE MediciGlobal
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lotus Pharmaceuticals, Inc. to Exhibit at the 2009 International Conference for Bioeconomy
2. AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast
3. Chindex International and Vital Images Sign Reseller Agreement
4. BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles
5. The International Medical Travel Association (IMTA) and Pacific Asia Travel Association (PATA) sign MOU to Promote Healthcare Travel
6. International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials
7. URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies
8. Kevin Niksarli, M.D. of Manhattan Lasik Center Reviews Pros and Cons of Contact Lenses vs. iLASIK at an International Meeting on 7/1/2009
9. Hamner Institutes and UNC Launch International Drug Safety Institute
10. Genomas Presents Drug-Specific Genetic Determinants of Statin Safety and Efficacy at the XV International Symposium on Atherosclerosis
11. Boston Scientifics Urology/Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology: